Surfactant Protein D Alters Allergic Lung Responses in Mice and Human Subjects
Overview
Authors
Affiliations
Background: Surfactant protein (SP) D has been proposed to be protective in allergic airway responses.
Objective: We aimed to determine the effect of SP-D deficiency on murine and human airway allergy.
Methods: Immunologic responses of SP-D gene-deficient mice (Sftpd-/-) at baseline and after 4 intranasal Aspergillus fumigatus exposures were assessed. In addition, the significance of a single nucleotide polymorphism (Met(11)Thr) in the human SP-D gene (known to decrease SP-D function) was investigated.
Results: Macrophage and neutrophil bronchoalveolar lavage fluid levels and large airway mucus production were increased in naive Sftpd-/- mice in association with increased lung CCL17 levels and CD4+ T cell numbers. T(H)2-associated antibody levels (IgG1 and IgE) were significantly lower in 4- to 5-week-old Sftpd-/- mice (P < .05). Accordingly, naive Sftpd-/- splenocytes released significantly less IL-4 and IL-13 on anti-CD3/CD28 stimulation (P < .01). After intranasal allergen exposures, a modest decrease in bronchoalveolar lavage fluid eosinophilia and IL-13 levels was observed in Sftpd-/- mice compared with values seen in wild-type mice in association with decreased airway resistance (P < .01). A single nucleotide polymorphism in the SFTPD gene, affecting SP-D levels and pathogen binding, was associated with decreased atopy in black subjects and potentially lower asthma susceptibility in white subjects.
Conclusion: Sftpd-/- mice have an impaired systemic T(H)2 response at baseline and reduced inflammation and airway responses after allergen exposure. Translational studies revealed that a polymorphism in the SFTPD gene was associated with lower atopy and possibly asthma susceptibility. Taken together, these results support the hypothesis that SP-D-dependent innate immunity influences atopy and asthma.
Shamim A, Abdul Aziz M, Saeed F, Kumari R, Mary Joseph A, Ponnachan P Front Immunol. 2025; 15:1491175.
PMID: 39742280 PMC: 11685232. DOI: 10.3389/fimmu.2024.1491175.
Morris S, Ocadiz-Ruiz R, Asai N, Malinczak C, Rasky A, Lombardo G Mucosal Immunol. 2024; 17(5):1072-1088.
PMID: 39069078 PMC: 11610113. DOI: 10.1016/j.mucimm.2024.07.007.
Jeffery W, Li B, Ng M, Li L, Goricki S, Ma L BMC Biol. 2023; 21(1):148.
PMID: 37365564 PMC: 10294541. DOI: 10.1186/s12915-023-01633-y.
Goode E, Marczylo E Clin Transl Allergy. 2023; 13(6):e12252.
PMID: 37357550 PMC: 10234180. DOI: 10.1002/clt2.12252.
Identification of a 7-mRNA signature as a prognostic biomarker in pediatric osteosarcoma.
Cui T, Guo J, Jin C Transl Cancer Res. 2022; 9(11):6733-6742.
PMID: 35117283 PMC: 8798948. DOI: 10.21037/tcr-20-2407.